Found 1 Enz. Inhib. hit(s) with Target = 'POU domain, class 2, transcription factor 2' and Ligand = 'BDBM330057' TargetPOU domain, class 2, transcription factor 2(Homo sapiens (Human))
Gilead Sciences, Inc.
US Patent
Gilead Sciences, Inc.
US Patent
Affinity DataIC50: 1.00E+4nMAssay Description:The dose dependent inhibition of OCT2 mediated uptake of a model substrate 14C-Tetraethylammonium (TEA) by test compounds was studied in wild-type an...More data for this Ligand-Target Pair
